| pubmed-article:21224685 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:21224685 | lifeskim:mentions | umls-concept:C0013216 | lld:lifeskim |
| pubmed-article:21224685 | lifeskim:mentions | umls-concept:C2239176 | lld:lifeskim |
| pubmed-article:21224685 | lifeskim:mentions | umls-concept:C0008838 | lld:lifeskim |
| pubmed-article:21224685 | lifeskim:mentions | umls-concept:C1134564 | lld:lifeskim |
| pubmed-article:21224685 | lifeskim:mentions | umls-concept:C0205179 | lld:lifeskim |
| pubmed-article:21224685 | pubmed:issue | 12 | lld:pubmed |
| pubmed-article:21224685 | pubmed:dateCreated | 2011-1-12 | lld:pubmed |
| pubmed-article:21224685 | pubmed:abstractText | Transcatheter arterial chemoembolization (TACE) was performed as the initial therapy for advanced hepatocellular carcinoma (HCC). However, no effective chemotherapy has been established for patients who did not respond to TACE, and for those the therapy was not suitable. Since 2004, transcatheter arterial infusion (TAI) chemotherapy using fine-powder cisplatin has been applied at our department to such cases mentioned before. This report described the therapeutic results of TAI therapy and presented a case of HCC accompanied by portal vein tumor thrombus (PVTT) for which the therapy was effective. | lld:pubmed |
| pubmed-article:21224685 | pubmed:language | jpn | lld:pubmed |
| pubmed-article:21224685 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21224685 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:21224685 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21224685 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21224685 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:21224685 | pubmed:month | Nov | lld:pubmed |
| pubmed-article:21224685 | pubmed:issn | 0385-0684 | lld:pubmed |
| pubmed-article:21224685 | pubmed:author | pubmed-author:DallosVV | lld:pubmed |
| pubmed-article:21224685 | pubmed:author | pubmed-author:OgawaKenjiK | lld:pubmed |
| pubmed-article:21224685 | pubmed:author | pubmed-author:KatsubeTakaoT | lld:pubmed |
| pubmed-article:21224685 | pubmed:author | pubmed-author:NaritakaYoshi... | lld:pubmed |
| pubmed-article:21224685 | pubmed:author | pubmed-author:YoshimatsuKaz... | lld:pubmed |
| pubmed-article:21224685 | pubmed:author | pubmed-author:ShiozawaShuni... | lld:pubmed |
| pubmed-article:21224685 | pubmed:author | pubmed-author:MasudaToshioT | lld:pubmed |
| pubmed-article:21224685 | pubmed:author | pubmed-author:TsuchiyaAkira... | lld:pubmed |
| pubmed-article:21224685 | pubmed:author | pubmed-author:InoseSatoshiS | lld:pubmed |
| pubmed-article:21224685 | pubmed:author | pubmed-author:AizawaMasakiM | lld:pubmed |
| pubmed-article:21224685 | pubmed:author | pubmed-author:UsuiTakebumiT | lld:pubmed |
| pubmed-article:21224685 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:21224685 | pubmed:volume | 37 | lld:pubmed |
| pubmed-article:21224685 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:21224685 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:21224685 | pubmed:pagination | 2702-4 | lld:pubmed |
| pubmed-article:21224685 | pubmed:meshHeading | pubmed-meshheading:21224685... | lld:pubmed |
| pubmed-article:21224685 | pubmed:meshHeading | pubmed-meshheading:21224685... | lld:pubmed |
| pubmed-article:21224685 | pubmed:meshHeading | pubmed-meshheading:21224685... | lld:pubmed |
| pubmed-article:21224685 | pubmed:meshHeading | pubmed-meshheading:21224685... | lld:pubmed |
| pubmed-article:21224685 | pubmed:meshHeading | pubmed-meshheading:21224685... | lld:pubmed |
| pubmed-article:21224685 | pubmed:meshHeading | pubmed-meshheading:21224685... | lld:pubmed |
| pubmed-article:21224685 | pubmed:meshHeading | pubmed-meshheading:21224685... | lld:pubmed |
| pubmed-article:21224685 | pubmed:meshHeading | pubmed-meshheading:21224685... | lld:pubmed |
| pubmed-article:21224685 | pubmed:meshHeading | pubmed-meshheading:21224685... | lld:pubmed |
| pubmed-article:21224685 | pubmed:meshHeading | pubmed-meshheading:21224685... | lld:pubmed |
| pubmed-article:21224685 | pubmed:meshHeading | pubmed-meshheading:21224685... | lld:pubmed |
| pubmed-article:21224685 | pubmed:meshHeading | pubmed-meshheading:21224685... | lld:pubmed |
| pubmed-article:21224685 | pubmed:meshHeading | pubmed-meshheading:21224685... | lld:pubmed |
| pubmed-article:21224685 | pubmed:meshHeading | pubmed-meshheading:21224685... | lld:pubmed |
| pubmed-article:21224685 | pubmed:meshHeading | pubmed-meshheading:21224685... | lld:pubmed |
| pubmed-article:21224685 | pubmed:year | 2010 | lld:pubmed |
| pubmed-article:21224685 | pubmed:articleTitle | [Efficacy of hepatic arterial infusion chemotherapy with cisplatin for advanced hepatocellular carcinoma]. | lld:pubmed |
| pubmed-article:21224685 | pubmed:affiliation | Dept. of Surgery, Tokyo Women's Medical University, Medical Center East. | lld:pubmed |
| pubmed-article:21224685 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:21224685 | pubmed:publicationType | English Abstract | lld:pubmed |
| pubmed-article:21224685 | pubmed:publicationType | Case Reports | lld:pubmed |
